PLoS ONE · 2012 · 70 citations · 11 references
Life SciencesImmunologyMicrobiologyHost-pathogen InteractionsImmunology Of Infectious DiseasesMucosal ImmunologyAntifungal AgentsAntifungal ResistanceAntifungal TherapyFungal InfectionsFungal PathogenesisOral CandidiasisAntifungal PeptidesAntifungal Resistance MechanismsCandida Albicans InfectionCandida TherapyConstant Region StructureMucosal Antifungal ImmunityNew Antifungal AgentsNovel Antifungal Drug Development
Synthetic peptides with sequences identical to fragments of the constant region of different classes (IgG, IgM, IgA) of antibodies (Fc-peptides) exerted a fungicidal activity in vitro against pathogenic yeasts, such as Candida albicans, Candida glabrata, Cryptococcus neoformans, and Malassezia furfur, including caspofungin and triazole resistant strains. Alanine-substituted derivatives of fungicidal Fc-peptides, tested to evaluate the critical role of each residue, displayed unaltered, increased or decreased candidacidal activity in vitro. An Fc-peptide, included in all human IgGs, displayed a therapeutic effect against experimental mucosal and systemic candidiasis in mouse models. It is intriguing to hypothesize that some Fc-peptides may influence the antifungal immune response and constitute the basis for devising new antifungal agents.
11
Peter G. Pappas, Barbara D. Alexander, David R. Andes et al. · Clinical Infectious Diseases · 2010 · 1.6K citations · Full text
Luciano Polonelli, Walter Magliani, Stefania Conti et al. · Infection and Immunity · 2003 · 102 citations · Full text